News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,147 signal articles · 105 in last 24h · 178,672 total before filter · latest 1h ago

105last 24h

3125last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1819 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: TEMsentiment: neutralSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Zacks5d agoneutral

TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside

TEM

MT Newswires5d agoneutral

Jefferies Upgrades Tempus AI to Hold From Sell, $70 Price Target

TEM

Simply Wall St.5d agoneutral

Why Tempus AI Stock Is Up 8.7% And What's Next

BMY TEM

Trefis5d agoneutral

How Long Can GRAIL Keep Burning Cash?

TEM

Simply Wall St.5d agoneutral

Tempus AI (TEM) Stock Looks Fully Priced Following Its 26% Run

TEM

Moby6d agoneutral

Tempus AI, Inc. Q3 2026 Earnings Call Summary

TEM

Motley Fool6d agoneutral

Tempus (TEM) Q3 2026 Earnings Call Transcript

TEM

Motley Fool6d agoneutral

Tempus AI Revenue Up 23%; Gains Cut Net Loss: Rapid Earnings Reaction

TEM

MarketBeat6d agoneutral

What Tempus AI (TEM) Said on Its Q3 Earnings Call

TEM

Zacks6d agoneutral

Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say

TEM

MT Newswires6d agoneutral

Sector Update: Healthcare Stocks Rise Premarket Monday

TEM

Barrons.com6d agoneutral

Tempus AI’s Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer

BMY MRK MRNA TEM

Associated Press6d agoneutral

Tempus: Q3 Earnings Snapshot

TEM

MT Newswires6d agoneutral

Tempus AI Swings to Q3 Non-GAAP Earnings, Revenue Rises; Shares Up Pre-Bell

TEM

Business Wire6d agoneutral

Tempus Reports Third Quarter 2026 Results

TEM

Stocktwits8d agoneutral

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks - But Pares Stake In This Pharma Giant That Had A Blowout Q3

TEM

GlobeNewswire9d agoneutral

Clinical Genomics Interpretation Platforms Global Market Report 2026 | Capitalize on AI and Cloud Growth Through 2030 with Thermo Fisher, Illumina, QIAGEN, and Tempus AI

TEM

GlobeNewswire9d agoneutral

Clinical Genomics Sequencing, Biobank, and Database Services Global Market to 2035 | Capitalize on AI and Precision Medicine: Illumina, Thermo Fisher, BGI Genomics, Tempus AI

TEM

Zacks9d agoneutral

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

TEM

Investor's Business Daily10d agoneutral

This Stock Offers Juicy Option Premiums, But Also Is Highly Risky

TEM

IPO-Edge.com11d agoneutral

IPO Edge NYSE Firesides Scheduled for Dec 7

TEM

Zacks11d agoneutral

Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline

SDGR TEM

24/7 Wall St.39d agoneutral

Cathie Wood Sold $110 Million of AMD and Bought Nvidia Instead

AMD CRWV SPCX TEM

Insider Monkey47d agoneutral

Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test

GS RXRX TEM

MarketBeat48d agoneutral

Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion

MRK MRNA TEM

Insider Monkey49d agoneutral

Tempus AI (TEM) Is Building a Heart Failure Agent That Never Sleeps

TEM

Simply Wall St.49d agoneutral

Tempus AI (TEM), What Is Behind The Latest Buzz?

TEM

Simply Wall St.50d agoneutral

Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative

TEM

Simply Wall St.50d agoneutral

Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes

TEM

Zacks51d agoneutral

Zacks Investment Ideas feature highlights: NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver

AMD MRNA SMCI TEM